July 15 (Reuters) - Propanc Biopharma Inc PPCBD.PK :
* PROPANC BIOPHARMA PROVIDES UPDATE ON PREPARATION OF PRP
FOR
CLINICAL TRIAL APPLICATION SUBMISSION AND RECENTLY COMPLETED
REVERSE STOCK SPLIT
* PROPANC BIOPHARMA INC - PLANS TO SUBMIT ITS FIRST CLINICAL
TRIAL
APPLICATION IN SECOND HALF OF 2019
* PROPANC BIOPHARMA INC - PLANS TO COMMENCE FIH STUDY IN
ADVANCED
CANCER PATIENTS FOR PRP DURING FIRST HALF OF 2020
Source text for Eikon: ID:nBwc25Jjra
Further company coverage: PPCBD.PK
((Reuters.Briefs@thomsonreuters.com;))